Determining how normal and leukemic stem cells behave in vivo, in a dynamic and noninvasive way, remains a major challenge. Most optical tracking technologies rely on the use of fluorescent or bioluminescent reporter genes, which need to be stably expressed in the cells of interest. Because gene transfer in primary leukemia samples represents a major risk to impair their capability to engraft in a xenogenic context, we evaluated the possibility to use gene transfer-free labeling technologies. The lipophilic dye 3,3,3,3 tetramethylindotricarbocyanine iodide (DiR) was selected among 4 nearinfrared (NIR) staining technologies. Unfortunately we report here a massive transfer of the dye occurring toward the neighbor cells both in vivo and in vitro. We further demonstrate that all lipophilic dyes tested in this study (1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine perchlorate [DiI], DiD, DiR, and PKH26) can give rise to microenvironmental contamination, including when used in suboptimal concentration, after extensive washing procedures and in the absence of phagocytosis or marked cell death. This was observed from all cell types tested. Eventually, we show that this microenvironmental contamination is mediated by both direct cell-cell contacts and diffusible microparticles. We conclude that tracking of labeled cells using non-genetically encoded markers should always be accompanied by drastic cross validation using multimodality approaches. (Blood. 2010;115(26): 5347-5354)
IntroductionDespite recent animated discussions, 1 xenotransplantation of human cells in immunodeficient animals remains the only available technique to analyze the "stemness" of human cancer-initiating cells. [2][3][4][5] Despite the wide use of this model, homing and dynamic behavior of injected cells depending on time remain largely unknown both for normal and malignant cells. Whole-body imaging (WBI) and intravital microscopy (IVM) provide powerful tools to longitudinally monitor the behavior of cancers in vivo 6,7 and to track and analyze normal and cancer-initiating cells in their microenvironment or niche. 8,9 Near-infrared optical imaging (NIR) represents a very attractive technology in this context by offering a relatively easy and cheap access to multimodality and multiscale in vivo imaging. 10,11 In vivo cell tracking using optical imaging technologies largely relies on the use of ectopic expression of reporter genes such as Luciferase (for bioluminescence) or on fluorescent proteins. To obtain such expression, cells have to be engineered in vitro so that the reporter gene can be integrated in their genome for stable expression over time. Because in vitro manipulation of primary leukemia samples represents a real risk to impede the functionality of the cells, gene transfer-free approaches would represent a major improvement in this context. 12 Various strategies have been reported to fluorescently label cells in vitro for subsequent tracking in vivo. [13][14][15][16] In the field of immunohematology, the succinimidyl ester of carb...